HOXB13/IL17RB-low breast cancers are predicted to respond to PIK3CA inhibitors independent of PIK3CA mutational status Baris Boyraz, Grace Kirkpatrick,Stefan T. Kaluziak,Robert Morris,Johannes Kreuzer,Wilhelm Haas,Anthony John Iafrate,Dennis SgroiCANCER RESEARCH(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要